September 02, 2014 7:54 PM ET

Healthcare Equipment and Supplies

Company Overview of Covidien Inc.

Executive Profile

Matthew J. Nicolella

Director, Covidien Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background

Mr. Matthew J. Nicolella serves as Chief Mergers & Acquisitions/Licensing Counsel of Tyco Healthcare Group LP. Mr. Nicolella serves as Vice President, Assistant Secretary and Director of USSC and Vice President He has been a Director of Power Medical Interventions, Inc., since September 2009. He serves as a Director at Covidien Inc. Mr. Nicolella served as a Director of Vnus Medical Technologies II, Inc.

Corporate Headquarters

15 Hampshire Street
Mansfield, Massachusetts 02048

United States

Phone: 508-261-8000
Fax: 508-261-6077

Board Members Memberships

Former Director
Director
2009-Present
Director

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Covidien Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.